Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized Placebo-Controlled Double-Blind Pilot Study.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Determinants of the severity of comorbid migraine in multiple sclerosis.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
Dimethyl fumarate - only an anti-psoriatic medication?
Do cortical lesions help us to distinguish MS from NMO?
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Atypical forms of optic neuritis.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
CD8-mediated inflammatory central nervous system disorders.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Interventions to evaluate fitness to drive among people with chronic conditions: Systematic review of literature.
Orbital Doppler evaluation of blood flow velocities in optic neuritis.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
ATX-MS-1467 - Positive Immunological data in Multiple Sclerosis: Final Phase I/IIa data shows safety and tolerability, plus efficacy
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
Does a waist-worn ActiGraph accelerometer quantify community ambulation in persons with multiple sclerosis?
[New therapies in multiple sclerosis].

Pages